Bernd Deny - IVF Hartmann Chief Officer

All Insiders . Switzerland . 
Stock . IVF Hartmann Holding . Stakeholders . Insider . Bernd Deny
VBSN Stock  CHF 151.00  1.00  0.67%   

Insider

Bernd Deny is Chief Officer of IVF Hartmann Holding
Age 57
Phone41 52 674 31 11
Webhttps://www.ivf.hartmann.info

IVF Hartmann Management Efficiency

The company has return on total asset (ROA) of 0.0315 % which means that it generated a profit of $0.0315 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0544 %, meaning that it generated $0.0544 on every $100 dollars invested by stockholders. IVF Hartmann's management efficiency ratios could be used to measure how well IVF Hartmann manages its routine affairs as well as how well it operates its assets and liabilities.
IVF Hartmann Holding has accumulated 428 K in total debt. IVF Hartmann Holding has a current ratio of 4.47, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist IVF Hartmann until it has trouble settling it off, either with new capital or with free cash flow. So, IVF Hartmann's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IVF Hartmann Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IVF to invest in growth at high rates of return. When we think about IVF Hartmann's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christian SchmittCembra Money Bank
N/A
Benno DemontGraubuendner Kantonalbank
N/A
Andreas LtscherGraubuendner Kantonalbank
N/A
Claudia Schumachermobilezone ag
N/A
Samantha HarnettLogitech International SA
47
Massimo RappariniLogitech International SA
N/A
Holger LaubenthalCembra Money Bank
51
Prakash ArunkundrumLogitech International SA
47
Volker GloeCembra Money Bank
55
Krista ToddLogitech International SA
N/A
Urs ScherrerMetall Zug AG
43
Ehrika GladdenLogitech International SA
N/A
Pascal PerritazCembra Money Bank
51
Ingrid SchaubAdval Tech Holding
N/A
Eric AnlikerCembra Money Bank
N/A
Matthias ReyMetall Zug AG
41
Ralf OstheiderAdval Tech Holding
N/A
Alastair CurtisLogitech International SA
N/A
Gregor Vogtmobilezone ag
44
Enrico LardelliGraubuendner Kantonalbank
57
Christof GassnerMetall Zug AG
N/A
IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company was founded in 1874 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF HARTMANN operates under Medical Instruments Supplies classification in Switzerland and is traded on Switzerland Exchange. It employs 323 people. IVF Hartmann Holding (VBSN) is traded on SIX Swiss Exchange in Switzerland and employs 312 people.

Management Performance

Return On Equity0.0544
Return On Asset0.0315

IVF Hartmann Holding Management Team

Elected by the shareholders, the IVF Hartmann's board of directors comprises two types of representatives: IVF Hartmann inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IVF. The board's role is to monitor IVF Hartmann's management team and ensure that shareholders' interests are well served. IVF Hartmann's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IVF Hartmann's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hannes Leu, Chief Officer
Bernd Deny, Chief Officer
Claus Martini, Chief Officer

IVF Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IVF Hartmann a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0544
Return On Asset0.0315
Profit Margin0.05 %
Operating Margin0.06 %
Current Valuation247.54 M
Shares Outstanding2.4 M
Shares Owned By Insiders71.77 %
Shares Owned By Institutions1.23 %
Price To Earning25.67 X
Price To Book2.01 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for IVF Stock Analysis

When running IVF Hartmann's price analysis, check to measure IVF Hartmann's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IVF Hartmann is operating at the current time. Most of IVF Hartmann's value examination focuses on studying past and present price action to predict the probability of IVF Hartmann's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IVF Hartmann's price. Additionally, you may evaluate how the addition of IVF Hartmann to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY